Clinical trial
Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I…
NCT00129220 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00129220 |
|---|---|
| Title | Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder |
| Official title | Placebo- and Haloperidol-Controlled Double-Blind Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | olanzapine, haloperidol, placebo |
| Enrollment | 224 |
| Start date | Jul 1, 2005 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Aug 11, 2005 |
| Last update posted | Dec 28, 2010 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: